Literature DB >> 2537361

Tumor necrosis factor as an activator of human granulocytes. Potentiation of the metabolisms triggered by the Ca2+-mobilizing agonists.

A Yuo1, S Kitagawa, I Suzuki, A Urabe, T Okabe, M Saito, F Takaku.   

Abstract

TNF stimulated superoxide (O2-) release directly in human granulocytes in a dose-dependent manner (1 to 1000 U/ml), although its potency was weak. TNF-induced O2- release was inhibited by cAMP agonists or ionomycin, and was not accompanied with an increase in cytoplasmic free Ca2+ [( Ca2+]i) and membrane potential changes (depolarization). These findings indicate that neither Ca2+ mobilization nor membrane depolarization is required for TNF-receptor-mediated cell activation. The pretreatment of human granulocytes with TNF enhanced O2- release and membrane depolarization in parallel stimulated by the receptor-mediated Ca2+-mobilizing agonists (FMLP, Con A, and wheat germ agglutinin) or the Ca2+ ionophore ionomycin, but not by PMA, a direct activator of protein kinase C. The optimal effect was obtained by pretreatment of cells with 100 U/ml TNF for 5 to 10 min at 37 degrees C, although the magnitude of enhancement varied according to the agonists used as subsequent stimuli. TNF did not affect an increase in [Ca2+]i stimulated by the Ca2+-mobilizing agonists, except Con A. Con A-induced increase in [Ca2+]i was enhanced by TNF in a dose-dependent manner. These diverse effects of TNF could be partly explained by the exclusive potentiation by TNF of the metabolic events triggered by an increase in [Ca2+]i.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537361

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

Review 2.  Regulation of neutrophil functions by proinflammatory cytokines.

Authors:  Takayuki Kato; Seiichi Kitagawa
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 3.  Relationship between diseases accompanied by tissue destruction and granulocytes with surface adrenergic receptors.

Authors:  Toru Abo; Toshihiko Kawamura; Hiroki Kawamura; Chikako Tomiyama-Miyaji; Yasuhiro Kanda
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Effects of chemotactic peptide f-Met-Leu-Phe (FMLP) on C3b receptor (CR1) expression and phagocytosis of microspheres by human neutrophils.

Authors:  J D Ogle; J G Noel; R M Sramkoski; C K Ogle; J W Alexander
Journal:  Inflammation       Date:  1990-06       Impact factor: 4.092

5.  Calpain inhibition impairs TNF-alpha-mediated neutrophil adhesion, arrest and oxidative burst.

Authors:  Andrew J Wiemer; Mary A Lokuta; Jill C Surfus; Sarah A Wernimont; Anna Huttenlocher
Journal:  Mol Immunol       Date:  2009-11-03       Impact factor: 4.407

6.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

7.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Effects of combination of tumor necrosis factor alpha and chemotactic peptide, f-Met-Leu-Phe, on phagocytosis of opsonized microspheres by human neutrophils.

Authors:  J D Ogle; J G Noel; R M Sramkoski; C K Ogle; J W Alexander
Journal:  Inflammation       Date:  1992-02       Impact factor: 4.092

9.  Interleukin-8 primes human neutrophils for enhanced superoxide anion production.

Authors:  A Wozniak; W H Betts; G A Murphy; M Rokicinski
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

10.  Modulation of transmembrane signalling in HL-60 granulocytes by tumour necrosis factor-alpha.

Authors:  K R McLeish; J B Klein; T Schepers; G Sonnenfeld
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.